These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
492 related articles for article (PubMed ID: 17609271)
1. Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor. Huh K; Zhou X; Hayakawa H; Cho JY; Libermann TA; Jin J; Harper JW; Munger K J Virol; 2007 Sep; 81(18):9737-47. PubMed ID: 17609271 [TBL] [Abstract][Full Text] [Related]
2. The membrane-associated ubiquitin ligase MARCHF8 stabilizes the human papillomavirus oncoprotein E7 by degrading CUL1 and UBE2L3 in head and neck cancer. Khalil MI; Yang C; Vu L; Chadha S; Nabors H; James CD; Morgan IM; Pyeon D J Virol; 2024 Feb; 98(2):e0172623. PubMed ID: 38226814 [TBL] [Abstract][Full Text] [Related]
3. Both Rb and E7 are regulated by the ubiquitin proteasome pathway in HPV-containing cervical tumor cells. Wang J; Sampath A; Raychaudhuri P; Bagchi S Oncogene; 2001 Aug; 20(34):4740-9. PubMed ID: 11498796 [TBL] [Abstract][Full Text] [Related]
4. Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system. Poirson J; Biquand E; Straub ML; Cassonnet P; Nominé Y; Jones L; van der Werf S; Travé G; Zanier K; Jacob Y; Demeret C; Masson M FEBS J; 2017 Oct; 284(19):3171-3201. PubMed ID: 28786561 [TBL] [Abstract][Full Text] [Related]
5. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53. Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502 [TBL] [Abstract][Full Text] [Related]
6. Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7. Gonzalez SL; Stremlau M; He X; Basile JR; Münger K J Virol; 2001 Aug; 75(16):7583-91. PubMed ID: 11462030 [TBL] [Abstract][Full Text] [Related]
7. Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions. von Knebel Doeberitz M; Rittmüller C; Aengeneyndt F; Jansen-Dürr P; Spitkovsky D J Virol; 1994 May; 68(5):2811-21. PubMed ID: 8151752 [TBL] [Abstract][Full Text] [Related]
8. The PTPN14 Tumor Suppressor Is a Degradation Target of Human Papillomavirus E7. Szalmás A; Tomaić V; Basukala O; Massimi P; Mittal S; Kónya J; Banks L J Virol; 2017 Apr; 91(7):. PubMed ID: 28100625 [TBL] [Abstract][Full Text] [Related]
9. Activation of Wnt signaling pathway by human papillomavirus E6 and E7 oncogenes in HPV16-positive oropharyngeal squamous carcinoma cells. Rampias T; Boutati E; Pectasides E; Sasaki C; Kountourakis P; Weinberger P; Psyrri A Mol Cancer Res; 2010 Mar; 8(3):433-43. PubMed ID: 20215420 [TBL] [Abstract][Full Text] [Related]
10. Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses. Howley PM; Münger K; Romanczuk H; Scheffner M; Huibregtse JM Princess Takamatsu Symp; 1991; 22():239-48. PubMed ID: 1668886 [TBL] [Abstract][Full Text] [Related]
11. SOCS1 [corrected] inhibits HPV-E7-mediated transformation by inducing degradation of E7 protein. Kamio M; Yoshida T; Ogata H; Douchi T; Nagata Y; Inoue M; Hasegawa M; Yonemitsu Y; Yoshimura A Oncogene; 2004 Apr; 23(17):3107-15. PubMed ID: 15021916 [TBL] [Abstract][Full Text] [Related]
12. The papillomavirus E7 oncoprotein is ubiquitinated by UbcH7 and Cullin 1- and Skp2-containing E3 ligase. Oh KJ; Kalinina A; Wang J; Nakayama K; Nakayama KI; Bagchi S J Virol; 2004 May; 78(10):5338-46. PubMed ID: 15113913 [TBL] [Abstract][Full Text] [Related]
13. Alteration of cell-cycle regulatory proteins in human oral epithelial cells immortalized by HPV16 E6 and E7. Sdek P; Zhang ZY; Cao J; Pan HY; Chen WT; Zheng JW Int J Oral Maxillofac Surg; 2006 Jul; 35(7):653-7. PubMed ID: 16513324 [TBL] [Abstract][Full Text] [Related]
14. High incidence of female reproductive tract cancers in FA-deficient HPV16-transgenic mice correlates with E7's induction of DNA damage response, an activity mediated by E7's inactivation of pocket proteins. Park JW; Shin MK; Lambert PF Oncogene; 2014 Jun; 33(26):3383-91. PubMed ID: 24013229 [TBL] [Abstract][Full Text] [Related]
15. Curcumin suppresses human papillomavirus oncoproteins, restores p53, Rb, and PTPN13 proteins and inhibits benzo[a]pyrene-induced upregulation of HPV E7. Maher DM; Bell MC; O'Donnell EA; Gupta BK; Jaggi M; Chauhan SC Mol Carcinog; 2011 Jan; 50(1):47-57. PubMed ID: 21061268 [TBL] [Abstract][Full Text] [Related]
16. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer. Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK Virol J; 2016 Apr; 13():60. PubMed ID: 27044426 [TBL] [Abstract][Full Text] [Related]
17. High-Risk Human Papillomavirus E7 Proteins Target PTPN14 for Degradation. White EA; Münger K; Howley PM mBio; 2016 Sep; 7(5):. PubMed ID: 27651363 [TBL] [Abstract][Full Text] [Related]
18. Structural basis for recognition of the tumor suppressor protein PTPN14 by the oncoprotein E7 of human papillomavirus. Yun HY; Kim MW; Lee HS; Kim W; Shin JH; Kim H; Shin HC; Park H; Oh BH; Kim WK; Bae KH; Lee SC; Lee EW; Ku B; Kim SJ PLoS Biol; 2019 Jul; 17(7):e3000367. PubMed ID: 31323018 [TBL] [Abstract][Full Text] [Related]
19. Regulation of HPV E7 Stability by E6-Associated Protein (E6AP). Vats A; Trejo-Cerro O; Massimi P; Banks L J Virol; 2022 Aug; 96(16):e0066322. PubMed ID: 35916535 [TBL] [Abstract][Full Text] [Related]
20. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells. Ding W; Hu Z; Zhu D; Jiang X; Yu L; Wang X; Zhang C; Wang L; Ji T; Li K; He D; Xia X; Liu D; Zhou J; Ma D; Wang H Clin Cancer Res; 2014 Dec; 20(24):6495-503. PubMed ID: 25336692 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]